LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

Inicio・Lista de Acciones・ResMed Inc

ResMed Inc

Cerrado

Sector Salud

243.51 0.4

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

243.26

Máximo

244.58

Métricas clave
By Trading Economics
Ingresos	19M 311M
Ventas	1.2B
P/B Media del Sector	29.45 106.547
BPA	2.2
Margen de beneficio	25.521
EBITDA	-67M 362M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	-1.46 downside

Dividendos
By Dow Jones
Próximas Ganancias	22 ene 2025
Fecha Próximo Dividendo	12 dic 2024
Próxima Fecha de Ex Dividendo	7 nov 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	744M 36B
Apertura anterior	243.11
Cierre anterior	243.51

Noticias sobre sentimiento de mercado

By Acuity

10%

90%

18 / 389 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

173.1 / 175.28 Soporte y Resistencia

ResMed Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

24 jun 2024, 17:43 UTC

Principales Movimientos del Mercado

Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update

25 oct 2024, 09:10 UTC

Ganancias

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25 oct 2024, 08:35 UTC

Ganancias

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

27 jun 2024, 16:01 UTC

Ganancias

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

24 jun 2024, 17:28 UTC

Principales Movimientos del Mercado

ResMed, Inspire Medical Shares Down After Eli Lilly Provides Sleep Apnea Study Update

26 abr 2024, 20:12 UTC

Ganancias

These Stocks Moved the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More -- Barrons.com

26 abr 2024, 20:09 UTC

Ganancias

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed -- IBD

26 abr 2024, 14:01 UTC

Ganancias

ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes -- IBD

29 ene 2024, 05:30 UTC

Ganancias

ResMed CEO: Weight-Loss Drugs Aren't Cutting Demand for Sleep Apnea Treatment -- Barrons.com

Comparación entre iguales

Cambio de precio

ResMed Inc Esperado

Precio Objetivo

By TipRanks

-1.46% caída

Estimación a 12 meses

Media 240.71 USD -1.46%

Máximo 283 USD

Mínimo 180 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para ResMed Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

12 ratings

Comprar

Mantener

Vender

De acuerdo con 12 analistas que ofrecen calificaciones bursátiles a para ResMed Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

173.1 / 175.28Soporte y Resistencia

Bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

18 / 389 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de ResMed Inc

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.